Assessment of arterial stiffness among schizophrenia-spectrum disorders using aortic pulse wave velocity and arterial compliance: A pilot study

Psychiatry Research

Volumn 215, Issue 1, 2014, Pages 14-19

  Phillips, Aaron A ^a   Warburton, Darren E R ^a   Flynn, Sean W ^a   Fredrikson, Diane ^a   Lang, Donna J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Arteriosclerosis; Cardiovascular risk; Schizophrenia

Indexed keywords

AMFEBUTAMONE; ARIPIPRAZOLE; BENZATROPINE; CLONAZEPAM; CLOZAPINE; ESCITALOPRAM; FLUOXETINE; FLUPENTIXOL; LITHIUM; LOXAPINE; OLANZAPINE; PALIPERIDONE; QUETIAPINE; RISPERIDONE;

ADULT; AGE; ARTERIAL STIFFNESS; ARTERY COMPLIANCE; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; HEART OUTPUT; HEART RATE; HEART STROKE VOLUME; HUMAN; MALE; NON INVASIVE MEASUREMENT; PILOT STUDY; PRIORITY JOURNAL; PULSE WAVE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SENSITIVITY AND SPECIFICITY; SMOKING; SYSTEMIC VASCULAR RESISTANCE;

ARTERIOSCLEROSIS; CARDIOVASCULAR RISK; SCHIZOPHRENIA;

ADULT; AORTA; BLOOD FLOW VELOCITY; BLOOD PRESSURE; FEMALE; HEART RATE; HUMANS; MALE; PILOT PROJECTS; PULSE WAVE ANALYSIS; SCHIZOPHRENIA; VASCULAR STIFFNESS; YOUNG ADULT;

EID: 84892855992     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2013.10.020     Document Type: Article

References (43)

1. Addington D., Addington J., Maticka-Tyndale E., Joyce J. Reliability and validity of a depression rating scale for schizophrenics. Schizophrenia Research 1992, 6:201-208.
2. Andreassen O.A., Djurovic S., Thompson W.K., Schork A.J., Kendler K.S., Apos Donovan O, Rujescu M.C., Werge D., Van De Bunt T., Morris M., McCarthy A.P., Gwas M.I., Consortium I.C.F.B.P., Group D.G.R.A.M., Roddey J.C., McEvoy L.K., Desikan R.S., Dale A.M. Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors. American Journal of Human Genetics 2013, 92:197-209.
3. Bar K.J., Boettger M.K., Berger S., Baier V., Sauer H., Yeragani V.K., Voss A. Decreased baroreflex sensitivity in acute schizophrenia. Journal of Applied Physiology 2007, 102:1051-1056.
4. Brown S. Excess mortality of schizophrenia. A meta-analysis. British Journal of Psychiatry 1997, 171:502-508.
5. Capasso R.M., Lineberry T.W., Bostwick J.M., Decker P.A., Sauver J. Mortality in schizophrenia and schizoaffective disorder: an Olmsted County, Minnesota cohort: 1950-2005. Schizophrenia Research 2008, 98:287-294.
6. Cavalcante J.L., Lima J.A., Redheuil A., Al-Mallah M.H. Aortic stiffness: current understanding and future directions. Journal of the American College of Cardiology 2011, 57:1511-1522.
7. Cecelja M., Chowienczyk P. Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension: a systematic review. Hypertension 2009, 54:1328-1336.
8. Correll C.U., Frederickson A.M., Kane J.M., Manu P. Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with second-generation antipsychotic drugs. Journal of Clinical Psychiatry 2006, 67:575-583.
9. De Hert M., Dekker J.M., Wood D., Kahl K.G., Moller H.-J. Cardiovascular disease and diabetes in people with severe mental illness. Revista de Psiquiatría y Salud Mental 2009, 2:49-59.
10. De Hert M., Vancampfort D., Correll C.U., Mercken V., Peuskens J., Sweers K., van Winkel R., Mitchell A.J. Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation. British Journal of Psychiatry 2011, 199:99-105.
11. Duprez D.A., Jacobs D.R., Lutsey P.L., Bluemke D.A., Brumback L.C., Polak J.F., Peralta C.A., Greenland P., Kronmal R.A. Association of small artery elasticity with incident cardiovascular disease in older adults: the multi-ethnic study of atherosclerosis. American Journal of Epidemiology 2011, 174:528-536.
12. Enger C., Weatherby L., Reynolds R.F., Glasser D.B., Walker A.M. Serious cardiovascular events and mortality among patients with schizophrenia. Journal of Nervous and Mental Disease 2004, 192:19-27.
13. Fleischhacker W.W., Cetkovich-Bakmas M., De Hert M., Hennekens C.H., Lambert M., Leucht S., Maj M., McIntyre R.S., Naber D., Newcomer J.W., Olfson M., Osby U., Sartorius N., Lieberman J.A. Comorbid somatic illnesses in patients with severe mental disorders: clinical, policy, and research challenges. Journal of Clinical Psychiatry 2008, 69(4):514-519.
14. Foley D.L., Morley K.I. Systematic review of early cardiometabolic outcomes of the first treated episode of psychosis. Archives of General Psychiatry 2011, 68:609-616.
15. Foulds H.J.A., Bredin S.S.D., Warburton D.E.R. The relationship between hypertension and obesity across different ethnicities. Journal of Hypertension 2012, 30:359-367.
16. Grey E., Bratteli C., Glasser S.P., Alinder C., Finkelstein S.M., Lindgren B.R., Cohn J.N. Reduced small artery but not large artery elasticity is an independent risk marker for cardiovascular events. American Journal of Hypertension 2003, 16:265-269.
17. Hennekens C.H., Hennekens A.R., Hollar D., Casey D.E. Schizophrenia and increased risks of cardiovascular disease. American Hearth Journal 2005, 150:1115-1121.
18. Israel A.K., Seeck A., Boettger M.K., Rachow T., Berger S., Voss A., Bar K.J. Peripheral endothelial dysfunction in patients suffering from acute schizophrenia: a potential marker for cardiovascular morbidity?. Schizophrenia Research 2011, 128:44-50.
19. Kay S.R., Flszbein A., Opfer L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 1987, 13:261-276.
20. Kim J.W., Park C.G., Hong S.J., Park S.M., Rha S.W., Seo H.S., Oh D.J., Rho Y.M. Acute and chronic effects of cigarette smoking on arterial stiffness. Blood Pressure 2005, 14:80-85.
21. Leucht S., Burkard T., Henderson J., Maj M., Sartorius N. Physical illness and schizophrenia: a review of the literature. Acta Psychiatrica Scandinavica 2007, 116:317-333.
22. Leung J.Y.T., Barr A.M., Procyshyn R.M., Honer W.G., Pang C.C.Y. Cardiovascular side-effects of antipsychotic drugs: the role of the autonomic nervous system. Pharmacology & Therapeutics 2012, 135:113-122.
23. Mattace-Raso F.U., Hofman A., Verwoert G.C., Wittemana J.C., Wilkinson I., Cockcroft J., McEniery C.M., Yasmin, Laurent S., Boutouyrie P., Bozec E., Hansen T.W., Torp-Pedersen C., Ibsen H., Jeppesen J., Vermeersch S.J., Rietzschel E., De Buyzere M., Gillebert T.C., Van Bortel L., Segers P., Vlachopoulos C., Aznaouridis C., Stefanadis C., Benetos A., Labat C., Lacolley P., Stehouwer C.D., Nijpels G., Dekker J.M., Ferreira I., Twisk J.W., Czernichow S., Galan P., Hercberg S., Pannier B., Guérin A., London G., Cruickshank J.K., Anderson S.G., Paini A., Agabiti Rosei E., Muiesan M.L., Salvetti M., Filipovsky J., Seidlerova J., Dolejsova M. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: "establishing normal and reference values". European Heart Journal 2010, 31:2338-2350.
24. McVeigh G.E., Finkelstein S.M., Cohn J.N. Assessment of arterial compliance in hypertension. Current Opinion in Nephrology and Hypertension 1993, 2:82-86.
25. Minzenberg M.J., Poole J.H., Benton C., Vinogradov S. Association of anticholinergic load with impairment of complex attention and memory in schizophrenia. American Journal of Psychiatry 2004, 161:116-124.
26. Minzenberg M.J., Yoon J.H. An index of relative central alpha-adrenergic receptor antagonism by antipsychotic medications. Experimental and Clinical Psychopharmacology 2011, 19:31-39.
27. Mitchell G.F., Parise H., Benjamin E.J., Larson M.G., Keyes M.J., Vita J.A., Vasan R.S., Levy D. Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study. Hypertension 2004, 43:1239-1245.
28. Newcomer J.W. Antipsychotic medications: metabolic and cardiovascular risk. Journal of Clinical Psychiatry 2007, 68:8-13.
29. Nichols W.W., Epstein B.J. Actions of selected cardiovascular hormones on arterial stiffness and wave reflections. Current Pharmaceutical Design 2009, 15:304-320.
30. Nichols W.W., O'Rourke M.F. McDonald's Blood Flow in Arteries: Theoretic, Experimental and Clinical Principles 2005, Hodder Arnold, Philadelphia, PA. 5th ed.
31. Phillips A.A., Bredin S.S.D., Cote A.T., Drury C.T., Warburton D.E.R. Aortic distensibility is reduced during intense lower body negative pressure and is related to low frequency power of systolic blood pressure. European Journal of Applied Physiology 2013, 113(3):785-792.
32. Phillips A.A., Cote A.T., Bredin S.S., Krassioukov A.V, Warburton D.E. Aortic stiffness increased in spinal cord injury when matched for physical activity. Medicine and Science in Sports and Exercise 2012, 44:2065-2070.
33. Phillips A.A., Cote A.T., Foulds H.J., Charlesworth S., Bredin S.S., Burr J., Ngai S., Ivey A., Drury C.T., Fougere R.J., Warburton D.E. A segmental evaluation of arterial stiffness before and after prolonged strenuous exercise. Applied Physiology, Nutrition, and Metabolism 2012, 37:690-696.
34. Raja M. Clozapine safety, 35 years later. Current Drug Safety 2011, 6:164-184.
35. Rehill N., Beck C.R., Yeo K.R., Yeo W.W. The effect of chronic tobacco smoking on arterial stiffness. British Journal of Clinical Pharmacology 2006, 61:767-773.
36. Saha S., Chant D., McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?. Archives of General Psychiatry 2007, 64:1123-1131.
37. Seeck A., Israel A.K., Bar K.J., Voss A. Dynamic microvascular blood flow analysis during post-occlusive reactive hyperemia test in patients with schizophrenia. Annals of Biomedical Engineering 2011, 39:1972-1983.
38. Song B.G., Park J.B., Cho S.J., Lee S.Y., Kim J.H., Choi S.M., Park J.H., Park Y.H., Choi J.-O., Lee S.-C., Park S.W. Pulse wave velocity is more closely associated with cardiovascular risk than augmentation index in the relatively low-risk population. Heart Vessels 2009, 24:413-418.
39. Tiihonen J., Lönnqvist J., Wahlbeck K., Klaukka T., Niskanen L., Tanskanen A., Haukka J. 11-Year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet 2009, 374:620-627.
40. Tsuchikura S., Shoji T., Kimoto E., Shinohara K., Hatsuda S., Koyama H., Emoto M., Nishizawa Y. Central versus peripheral arterial stiffness in association with coronary, cerebral and peripheral arterial disease. Atherosclerosis 2010, 211:480-485.
41. Vlachopoulos C., Aznaouridis K., Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. Journal of the American College of Cardiology 2010, 55:1318-1327.
42. Wildgust H.J., Beary M. Review: are there modifiable risk factors which will reduce the excess mortality in schizophrenia?. Journal of Psychopharmacology 2010, 24:37-50.
43. Wildgust H.J., Hodgson R., Beary M. The paradox of premature mortality in schizophrenia: new research questions. Journal of Psychopharmacology 2010, 24:9-15.